Content by Max Delbrück Center for Molecular Medicine in the Helmholtz Association
New therapeutic strategy uses CRISPR-Cas9 to repair T cells that are defective due to rare disease of the immune system
| 3 min read
While deep learning is a very powerful tool, its use in genomics has been limited
| 3 min read
Page 1 of 1 - 2 Total Items
